Skip to content

Orthorexia Nervosa in Postmenopausal Osteoporosis

Fragile Bones, Strong Obsessions: A Controlled Study on Orthorexia Nervosa, Body Image and Mood in Postmenopausal Women With Osteoporosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06947213
Enrollment
128
Registered
2025-04-27
Start date
2025-04-20
Completion date
2025-05-20
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information regarding the duration of osteoporosis diagnosis, current treatments, history of fractures, history of falls, comorbidities, and smoking status will be collected. Femoral neck and L1-L4 T-scores and bone mineral density values obtained from existing DXA scans will be documented. Orthorexia nervosa-related symptoms will be assessed using the ORTO-11 scale, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and body image will be assessed using the Body Appreciation Scale-2.

Interventions

None listed

Sponsors

Beylikduzu State Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
55 Years to 75 Years

Inclusion criteria

* Women between 55-75 years * Women diagnosed with osteoporosis based on DXA measurements performed within the past six months. * Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls). * Willingness to participate and provision of written informed consent.

Exclusion criteria

* Refusal to participate in the study. * Diagnosed psychiatric disorders. * Cognitive impairment. * Presence of malignancy. * Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome). * Use of glucocorticoids. * Use of medications affecting mood.

Design outcomes

Primary

MeasureTime frameDescription
ORTO-11 ScaleBaselineThe ORTO-11 assesses orthorexic tendencies, which refer to an unhealthy obsession with healthy eating. It consists of 11 items rated on a 4-point Likert scale. Total scores range from 11 to 44, with lower scores indicating a higher risk of orthorexia nervosa.

Secondary

MeasureTime frameDescription
Body Appreciation Scale-2 (BAS-2)BaselineThe BAS-2 assesses positive body image and appreciation of one's body. It consists of 10 items rated on a 5-point Likert scale (1 = Never, 5 = Always). Total scores range from 10 to 50, with higher scores indicating greater body appreciation.

Other

MeasureTime frameDescription
Hospital Anxiety and Depression Scale (HADS)- Anxiety ScoreBaselineThe HADS-A subscale evaluates symptoms of anxiety. It consists of 7 items, each scored between 0 and 3. The total score ranges from 0 to 21, with higher scores indicating higher levels of anxiety.
Hospital Anxiety and Depression Scale (HADS)- Depression ScoreBaselineThe HADS-D subscale evaluates symptoms of depression. It consists of 7 items, each scored between 0 and 3. The total score ranges from 0 to 21, with higher scores indicating higher levels of depression.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026